Pfizer is buying sickle cell drug maker Global Blood Therapeutics in an approximately $5.4 billion deal as it looks to accelerate growth after its revenue soared during the pandemic
Related posts
-
Protesters crowd into streets, parks and plazas at anti-Trump ‘No Kings’ demonstrations across US
PHILADELPHIA -- Demonstrators crowded into streets, parks and plazas across the U.S. on Saturday to protest... -
Suburban man donates his kidney to help former neighbor’s son
How many times in a person’s life does one have the chance to give someone else... -
Minnesota Gov. Tim Walz: former House speaker and husband killed in politically motivated shooting
Minnesota Gov. Tim Walz says former state House Speaker Melissa Hortman and her husband were killed...